From July 31 to August 3, the 38th national pharmaceutical industry information conference in 2021 was grandly held in Jinan. After winning the honor list of "the most growing enterprise in China's pharmaceutical industry" in 2019 and 2020, wanbond Pharmaceutical Group was once again listed in the list of "the most growing enterprise in China's pharmaceutical industry in 2021" by relying on its strong enterprise strength and remarkable brand reputation.

From July 21 to 25, the 2021 mith Conference (full name: China Pharmaceutical and health industry symbiosis Conference) was grandly held in Kunming, and Wanbang xinnuokan, the core product of wanbond Pharmaceutical Group, was held ® After the Ginkgo biloba dropping pill was listed in the "Chinese medicine · brand list" in 2020, it was once again listed as the only Ginkgo biloba preparation variety in the list and the hospital terminal in the "Chinese medicine · brand list" in 2021. This is not only a comprehensive symbol of enterprise strength and influence, but also a prominent manifestation of product competitiveness and brand strength.

On the evening of July 21, 2021, the awarding ceremony of "2020 top 100 series list of China's pharmaceutical industry" was grandly held in Kunming. Under the leadership of chairman Mr. Zhao Shouming, wanbond pharmaceutical Holding Group Co., Ltd. was successfully selected into the sub list of "2020 top 100 series list of China's pharmaceutical industry" with solid R & D and production strength and steady market promotion ability "Top 100 ranking list of Chinese traditional medicine enterprises in 2020" and won the title of "top 100 enterprise" in "top 100 ranking list of Chinese traditional medicine enterprises in 2020".

On April 30, 2021, with the first box of fully qualified disposable vaccine syringes coming off the assembly line, wanbond medical technology polymer business unit located in Wenling, Zhejiang Province was officially completed and put into operation! This marks that the wanbond China Africa science and Technology Industrial Park, which has been built for two years, has been officially put into use.

On March 26, 2021, the launching meeting of the Ministry of industry and information technology's "2020 industrial technology based public service platform project - public service platform for the industrialization of innovative achievements in the field of medical equipment" was held in Taizhou. Shu min, deputy director of the industrial development promotion center of the Ministry of industry and information technology, Jin Xin, a first-class researcher of the Department of economy and information technology of Zhejiang Province, Chen Tingchen, vice mayor of Taizhou Municipal People's government, attended the meeting and delivered a speech. Zhao Shouming, chairman of wanbond Medical Technology Co., Ltd., and other representatives of project cooperation units attended the meeting.

On October 21, 2020, academician Tang xican of the Chinese Academy of Engineering visited wanbond pharmaceutical for investigation, guidance, discussion and exchange, accompanied by relevant personnel of Wenling Association for science and technology. Academician Tang xican went deep into the workshop to observe the product production, listened carefully to the key technologies and processes of drug production and quality management and the construction plan of new industrialization support platform in the future, and spoke highly of the enterprise's ability to improve product quality and production efficiency, promote the transformation and application of scientific and technological achievements, and improve product added value.